Who are we ?
Groff North America (Groff NA) is on a mission to help unlock the tremendous potential of Cannabis-based medicines in the U.S and overseas. Having received authorization from the DEA to grow 100% federally-legal Cannabis, we now have a unprecidented pathway to expand the research, development and manufacture of Cannabis therapeutics.
DEA SCHEDULE I REGISTRATIONS
In 2021, Groff NA was awarded the following Suite of schedule I registrations:
- Schedule I Bulk Manufacturing
Bulk Manufacture registration allows for the cultivation, extraction, and processing of federally-legal Cannabis.
- Schedule I Marijuana Non-Bulk Manufacturing (Patient Dose)
Non-Bulk Manufacturing (Patient Dose Form) registration allows Groff NA to take Cannabis grown under the Bulk Manufacturing registration and produce precise dosed forms for clinical trials and for FDA-approved drugs.
- Schedule I Importer
Importer registration allows Groff NA to import Cannabis flower, genetics, and extracts from anywhere in the world for use in our US operations.
- Schedule I Exporter
Exporter registration allows Groff NA to export Cannabis flower and Cannabis preparations to any of the 150+ signatory countries in the UN Single Convention on Narcotics.
- Schedule I Researcher
Researcher registration allows Groff NA to conduct its own research on Cannabis based therapies. This also allows Groff NA to collaborate with researchers working on new Cannabis- based drug development and scientific advancement.
- Schedule I Analytical Lab
Analytical Lab allows Groff NA to commercially test Cannabis at the highest standards possible.
Groff North America products & Services
Active Pharmaceutical Ingredient (api) Manufacturing
Pharmaceutical Development
Legal Hemp and Cannabis Extraction
Import and Export Cannabis Worldwide
Custom formulation
If you are looking to formulate using THC, CBD, Terpenes, or one of our many other Cannabinoid Isolates, Groff NA is here to help!